Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Attention Deficit Disorder With Hyperactivity, Cocaine-Related Disorders, Substance-Related Disorders
In brief
Dextroamphetamine is commonly used to treat ADHD, and recent evidence suggests that this medication may decrease drug use in individuals dependent on cocaine. Thus, the present pilot study will determine the ability of dextroamphetamine to treat individuals with both cocaine dependence and ADHD.
Key facts
- Study ID
- NCT00514202
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 5
- Starts
- 2007-08-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2012-02-22
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide informed consent
- Generally good health except for problems related to drug use
- Meet DSM criteria for cocaine dependence and ADHD
- Have stable living situation
You may not qualify if…
- DSM diagnosis for current psychotic, anxiety disorders as well as current substance dependence (with the exception of marijuana and nicotine)
- Current use of prescription medications
- Females who are currently pregnant or nursing
- History of significant acute or chronic physical illness
- History of or current liver disease
- Existing cardiovascular disease
- Plans to leave metropolitan area within 3 months
- Probation or parole with constraints that preclude full study participation
Where it is running
- University of Texas Health Science Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.